Latest VTVT reports update at 2023-08-11: 2023-Q2 ∙ 2022-Q4 ∙ 2022-Q2

vTv Therapeutics VTVT

$ 26.83 5.22%

vTv Therapeutics Financial Statements 2011-2024 | VTVT

Annual Financial Statements vTv Therapeutics

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	-	67.6 M	34.4 M	75 M	53.8 M	60 M	-	-	-	-
Shares	-	-	-	30.3 M	12.4 M	9.69 M	9.55 M	8.28 M	-	-	-	-
Historical Prices	0.87	0.995	1.86	1.7	2.65	6.01	4.83	6.81	-	-	-	-
Net Income	-19.2 M	-13 M	-8.5 M	-13 M	-7.91 M	-16.1 M	-16.4 M	-27.5 M	-36.1 M	-48.2 M	-	-
Revenue	2.02 M	4 M	6.41 M	2.76 M	12.4 M	291 K	634 K	519 K	1.55 M	976 K	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	519 K	1.55 M	976 K	-	-
Operating Income	-22.5 M	-21.7 M	-11.9 M	-20.9 M	-19.8 M	-50.7 M	-55 M	-38.1 M	-28.9 M	-35.8 M	-	-
Interest Expense	15 K	12 K	692 K	1.83 M	3.29 M	3.09 M	398 K	108 K	286 K	476 K	-	-
EBITDA	-22.4 M	-21.6 M	-11.8 M	-20.9 M	-19.6 M	-50.5 M	-54.8 M	-37.6 M	-28 M	-34.7 M	-	-
Operating Expenses	24.6 M	25.7 M	18.3 M	23.7 M	32.3 M	51 M	55.7 M	38.7 M	30.4 M	36.8 M	-	-
General and Administrative Expenses	12.2 M	12.3 M	7.25 M	8.54 M	9.22 M	11.3 M	9.91 M	9.08 M	11.7 M	11.4 M	-	-

All numbers in USD currency

Quarterly Income Statement vTv Therapeutics

	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-5.62 M	-4.5 M	-	-4.26 M	-3.15 M	-7.01 M	-	-1.09 M	-608 K	-4.24 M	-	-1.53 M	-3.37 M	-4.72 M	-4.4 M	-3.61 M	-2.88 M	-2.16 M	-1.09 M	-796 K	-3.07 M	-2.95 M	-4.31 M	-3.65 M	-3.96 M	-4.22 M	-4.05 M	-3.99 M	-4.46 M	-3.85 M	-3.17 M	-4.1 M	-10.4 M	-9.81 M	-7.72 M	-5.87 M	-7.4 M	-15.1 M	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	9 K	2 M	-	3 M	9 K	987 K	-	7 K	8 K	8 K	7 K	8 K	1.83 M	921 K	4.52 M	3.38 M	2.47 M	2.06 M	233 K	15 K	13 K	30 K	38 K	38 K	182 K	376 K	226 K	133 K	110 K	50 K	934 K	400 K	201 K	14 K	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-8 M	-7.43 M	-	-5.69 M	-4.03 M	-6.48 M	-	-1.6 M	-4.67 M	-4.28 M	-	-2.83 M	-4.2 M	-6.65 M	-6.39 M	-5.42 M	-4.79 M	-4.29 M	-351 K	-1.48 M	-8.86 M	-9.13 M	-12.8 M	-11.5 M	-12.6 M	-13.8 M	-13.3 M	-13.5 M	-14.6 M	-13.5 M	-11.1 M	-9.44 M	-7.89 M	-9.72 M	-6.67 M	-5.52 M	-7.19 M	-9.52 M	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2 K	-	-	8 K	-	1 K	-	6 K	2.9 M	-	-	235 K	222 K	168 K	-	404 K	514 K	626 K	-	822 K	870 K	855 K	-	849 K	832 K	559 K	-	3 K	1 K	2 K	-	-1 K	-1.51 M	660 K	-	-25 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-7.4 M	-	-5.62 M	-3.98 M	-6.46 M	-	-1.54 M	-4.62 M	-4.26 M	-	-2.76 M	-4.16 M	-6.62 M	-6.39 M	-5.4 M	-4.78 M	-4.28 M	-351 K	-1.37 M	-8.78 M	-9.09 M	-12.8 M	-11.4 M	-12.5 M	-13.7 M	-13.3 M	-13.3 M	-14.5 M	-13.5 M	-11.1 M	-9.08 M	-7.64 M	-9.59 M	-6.67 M	-4.84 M	-7.19 M	-9.52 M	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	8 M	7.43 M	-	5.69 M	4.04 M	8.48 M	-	4.6 M	4.68 M	5.27 M	-	2.84 M	4.2 M	6.65 M	-	5.43 M	6.62 M	5.21 M	-	4.86 M	11.3 M	11.2 M	-	11.6 M	12.6 M	13.8 M	-	13.6 M	14.8 M	13.9 M	-	9.57 M	8 M	9.77 M	-	5.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.31 M	3.48 M	-	2.63 M	1.83 M	5.35 M	-	2.22 M	2.24 M	2.16 M	-	1.07 M	1.7 M	2.45 M	-	1.77 M	2.39 M	2.39 M	-	2.16 M	2.74 M	2.26 M	-	2.57 M	3 M	2.82 M	-	2.4 M	2.67 M	2.58 M	-	2.42 M	2.3 M	2 M	-	1.59 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency